• Home
  • Stock
  • Aarti Pharmalabs Fundamental Analysis
  • Aarti Pharmalabs Fundamental Analysis

Aarti Pharmalabs fundamental analysis

AARTIPHARM

HealthcareMid

679.15

1.65 (-0.24%)
Last updated on 25 Nov, 2025 | 13:03 IST
BUYSELL

The current prices are delayed, login to your account for live prices

Aarti Pharmalabs Fundamentals

P/E Ratio

26.24

P/B Ratio

3.07

Div. Yield

0.72

Sector P/E

37.28

Sector P/B

3.6

Sec. Div. Yield

0.57

  • Aarti Pharmalabs Fundamentals is currently trading with a P/E Ratio of 26.24, compared to the sector average of 37.28. Its P/B Ratio stands at 3.07, while the sector’s is 3.6. In terms of returns, the stock offers a Dividend Yield of 0.72%, which is than the sector’s 0.57%.

Aarti Pharmalabs Score Card

  • Price

    Attractive

  • Growth

    Good

  • Quality

    Good

  • Management

    Good

  • On its scorecard, Aarti Pharmalabs reflects: Price – Attractive, Growth – Good, Quality – Good, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.